After a cancer vaccine’s first success, the race is on to expand the impact The positive Phase 3 melanoma study comes after 100 years of ‘bad news’

https://www.statnews.com/2026/10/25/mrna-cancer-vaccine-merck-moderna-esmo-intismeran-next-applications/ By Andrew JosephOct. 25, 2026 Europe Correspondent